Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes

被引:159
作者
Campisi, J
机构
[1] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA
[2] Buck Inst Age Res, Novato, CA 94945 USA
关键词
antagonistic pleiotropy; apoptosis; cancer; cellular senescence; DNA damage response; neurodegeneration; p53; telomeres;
D O I
10.1016/S0531-5565(02)00152-3
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 [法学]; 0303 [社会学]; 100203 [老年医学];
摘要
Aging in complex multi-cellular organisms such as mammals entails distinctive changes in cells and molecules that ultimately compromise the fitness of adult organisms. These cellular and molecular changes lead to the phenotypes we recognize as aging. This review discusses some of the cellular and molecular changes that occur with age, specifically changes that occur as a result of cellular responses that evolved to ameliorate the inevitable damage that is caused by endogenous and environmental insults. Because the force of natural selection declines with age, it is likely that these processes were never optimized during their evolution to benefit old organisms. That is, some age-related changes may be the result of gene activities that were selected for their beneficial effects in young organisms, but the same gene activities may have unselected, deleterious effects in old organisms, a phenomenon termed antagonistic pleiotropy. Two cellular processes, apoptosis and cellular senescence, may be examples of antagonistic pleiotropy. Both processes are essential for the viability and fitness of young organisms, but may contribute to aging phenotypes, including certain age-related diseases. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:5 / 11
页数:7
相关论文
共 74 条
[1]
Adams CS, 1998, ANAT RECORD, V250, P418
[2]
Almeida-Porada G, 2001, Rev Clin Exp Hematol, V5, P26, DOI 10.1046/j.1468-0734.2001.00027.x
[3]
Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress [J].
Amundson, SA ;
Myers, TG ;
Fornace, AJ .
ONCOGENE, 1998, 17 (25) :3287-3299
[4]
ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223
[5]
Telomere states and cell fates [J].
Blackburn, EH .
NATURE, 2000, 408 (6808) :53-56
[6]
Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[7]
p53 variants predisposing to cancer are present in healthy centenarians [J].
Bonafè, M ;
Olivieri, F ;
Mari, D ;
Baggio, G ;
Mattace, R ;
Sansoni, P ;
De Benedictis, G ;
De Luca, M ;
Bertolini, S ;
Barbi, C ;
Monti, D ;
Franceschi, C .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (01) :292-295
[8]
Tumor suppressors and oncogenes in cellular senescence [J].
Bringold, F ;
Serrano, M .
EXPERIMENTAL GERONTOLOGY, 2000, 35 (03) :317-329
[9]
Campisi J, 2000, IN VIVO, V14, P183
[10]
Aging and cancer: The double-edged sword of replicative senescence [J].
Campisi, J .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (04) :482-488